Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608855 · ClinicalTrials.gov registry record · NA
Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00608855: Completed NA study, sponsored by Mayo Clinic.
NCT00608855 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608855, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
RATIONALE: Percutaneous cryoablation may help relieve pain caused by bone metastases. PURPOSE: This clinical trial is studying the side effects and how well percutaneous cryoablation works in treating patients with painful bone metastases.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE pain therapy
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-11 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608855
The ClinicalTrials.gov registry entry for NCT00608855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT00608855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00608855 about?
NCT00608855 is a clinical study titled "Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases". RATIONALE: Percutaneous cryoablation may help relieve pain caused by bone metastases. PURPOSE: This clinical trial is studying the side effects and how well percutaneous cryoablation works in treating patients with painful bone metastases.
What is the current status of trial NCT00608855?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00608855?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), pain therapy (PROCEDURE), cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00608855?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.